Skip to main content
. 2022 Oct 7;28(37):5469–5482. doi: 10.3748/wjg.v28.i37.5469

Table 2.

Preoperative imaging characteristics of patients with pancreatic cystic neoplasms

Characteristic Training cohort
Validation cohort
P value
n = 187 (64.5%)
n = 103 (35.5%)
Tumor involve the head of pancreas 0.239
Yes 65 (34.8) 43 (41.7)
No 122 (65.2) 60 (58.3)
Bile duct dilation 0.106
No 174 (93.0) 90 (87.4)
Yes 13 (7.0) 13 (12.6)
Tumor size in mm 0.254
< 40 158 (84.5) 92 (89.3)
≥ 40 29 (15.5) 11 (10.7)
Intratumoral septum 0.264
No 76 (40.6) 35 (34.0)
Yes 111 (59.4) 68 (66.0)
Cyst wall enhancement 0.244
No 118 (63.1) 72 (69.9)
Yes 69 (36.9) 31 (30.1)
Cyst wall thickening 0.709
No 178 (95.2) 97 (94.2)
Yes 9 (4.8) 6 (5.8)
Enhanced mural nodules 0.126
No 148 (79.1) 89 (86.4)
Yes 39 (20.9) 14 (13.6)
Intracapsular calcification 0.117
No 162 (86.6) 82 (79.6)
Yes 25 (13.4) 21 (20.4)
Main pancreatic duct dilatation 0.419
No 122 (65.2) 72 (69.9)
Yes 65 (34.8) 31 (30.1)